Latest Breaking News On - Adam kaplin - Page 5 : comparemela.com

MIRA Pharmaceuticals, Inc Discusses Potential of Revolutionary THC Analog Drug, MIRA1a, with The Stock Day Podcast

MIRA Pharmaceuticals, Inc Discusses Potential of Revolutionary THC Analog Drug, MIRA1a, with The Stock Day Podcast
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKevin davisJoe mcgurkAdam kaplinErez aminovMichael kimPharmaceuticals incCompany registration statement on formUs drug enforcement administrationPharmaceuticals inc nasdaqStock day podcastStock dayChief scientific officerJohns hopkins ketamineStock day mediaEnforcement administration

Form 424B1 MIRA PHARMACEUTICALS,

Form 424B1 MIRA PHARMACEUTICALS,
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaCzech republicJohns hopkins universityBlue skyGeorgetown universityDistrict of columbiaBay shoreUnited kingdomNew jerseyCornell universityNew yorkFlorida international universityMontgomery countyState of floridaJonnier williams

Biopharma Company Working On Synthetic THC Drug To Treat Anxiety Launches NASDAQ IPO - Mira Pharmaceuticals (NASDAQ:MIRA)

Pre-clinical-stage biopharma company, MIRA Pharmaceuticals (NASDAQ: MIRA) launched its initial public offering Thursday and is trading $6.72 per share at the time of reporting.

Adam kaplinJohns hopkins school of medicineJohns hopkins multiple sclerosis centerJohn hopkins universityJohns hopkins schoolPrincipal neuro psychiatric consultantJohns hopkins ketamine clinicJohns hopkins university school

What Top MS Researchers Want You to Know About MS Care and Treatment Right Now

Neurology experts funded by the Center Without Walls presented the latest developments in MS research at the annual Race to Erase MS Forum.

United statesEllen mowryLos angelesJohns hopkinsLilyana amezcuaAdam kaplinRohit bakshiMymd pharmaceuticalsJohns hopkins university in baltimoreUniversity of southern californiaHarvard medical schoolRelapses versus pseudorelapsesSouthern californiaResearch looksHow aggressivelyTreat early

Long Covid Study: Symptoms Can Last At Least 15 Months

Medical researchers determine neurological symptoms from Covid-19 can last well over a year and so far, there's no clear explanation.

United statesIgor koralnikJohns hopkinsAdam kaplinNational institutes of healthGovernment accountability officeTranslational neurologytellLong covidNorthwestern medicineJohns hopkins post acuteGovernment accountabilityInternal medicineNational institutes